Sound Choice Pharmaceutical Institute is a Noncommercial Research Organizations business in Seattle, WA.
| Business Name: | Sound Choice Pharmaceutical Institute |
| Categorized In: | Noncommercial Research Organizations |
| Address: | 1749 Dexter Avenue North, Seattle, WA 98109 |
| Phone Number: | (206) 906-9922 |
| Contact Person: | Theresa A Deisher |
| NAICS Code: | 541720 |
| SIC Code: | 8733 |
| Business Type: | B2B (Business to Business) |
| Founding Year: | 2008 |
| Employee #: | 1 to 4 |
| Location Type: | Single Location |
| Annual Revenue ($): | $100.000 to $499.999 |
| Share This Business: | |
| Similar Businesses: |
American Cancer Society - Seattle, WA 98109 Aikido Institute Seattle - Seattle, WA 98109 Washington State Special - Seattle, WA 98109 Samir M Hanash - Seattle, WA 98109 Leland Hartwell Phd - Seattle, WA 98109 Institute For Analysis Of - Seattle, WA 98109 Quellos High Throughput Screening Core - Seattle, WA 98109 Sage Bionetworks - Seattle, WA 98109 |
Sound Choice Pharmaceutical Institute, a stable growing company under Noncommercial Research Organizations, is being run by Theresa A Deisher. Since , their sales have been favorable and consistent at $100.000 to $499.999. Company location coordinates are: 47.635827,-122.34255.
It can be reached by dialing (206) 906-9922, and you could get in touch with their sales team in 1749 Dexter Avenue North, Seattle, Washington WA 98109. Visit their website at: to know more about the company’s history, products and services, as well as frequently asked questions and privacy policies.
Special deals are also offered from time to time. Their professional and honest business transactions fortifies both consumers and businesses in their B2B segments.
Their modest but solid single location houses 1 to 4 staff members. All are benefiting from the company’s generous programs and sound training solutions.
You can learn more by checking their classification codes: SIC – 8733 and NAIC – 541720. Call the hotline stated above for faster transaction and queries. Sound Choice Pharmaceutical Institute would like to hear from you.